Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.18M Sell
2,801
-103
-4% -$41.1K 0.42% 53
2026
Q2
$1.05M Sell
2,904
-399
-12% -$137K 0.39% 56
2026
Q1
$1.16M Sell
3,303
-164
-5% -$58.5K 0.47% 51
2025
Q4
$1.13M Sell
3,467
-28
-0.8% -$8.88K 0.45% 52
2025
Q3
$986K Sell
3,495
-365
-9% -$106K 0.4% 54
2025
Q2
$1.08M Sell
3,860
-8
-0.2% -$2.27K 0.48% 54
2025
Q1
$1.21M Buy
3,868
+51
+1% +$15.1K 0.54% 47
2024
Q4
$995K Buy
+3,817
New +$1.13M 0.44% 54

Other funds holding AMGN

ANB Bank's AMGN Position: Q3 2026 in Review

ANB Bank reduced its Amgen (AMGN) stake by 3.5% in Q3 2026, selling an estimated $41.1K and leaving 2,801 shares worth $1.18M. The position accounts for 0.42% of the portfolio, ranked #53.

ANB Bank first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.21M in Q1 2025. 2,584 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • ANB Bank held 2,801 shares of Amgen worth $1.18M as of Q3 2026.
  • ANB Bank sold 103 Amgen shares in Q3 2026, an estimated $41.1K.
  • Amgen made up 0.42% of ANB Bank's portfolio in Q3 2026, its #53 holding.
  • ANB Bank first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • ANB Bank's Amgen position peaked at $1.21M in Q1 2025.
  • 2,584 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on ANB Bank's 13F filing for Q3 2026, filed 9 Oct 2026.